Hematology CPT & HCPCS Families Coded
Clean Claim Rate
Years in U.S. Medical Billing
Hematology practices without strong infusion hierarchy and J-code controls commonly lose 10 to 20% of revenue to administration sequencing errors, dosage-to-unit mismatches, and unbilled drug wastage. Most of it traces back to a small number of recurring coding decisions, which is exactly where specialty-specific billing pays for itself.
Where Hematology billing actually goes wrong
Hematology billing, done right
The coding decisions that cause most hematology denials, handled by billers who know the specialty, not just the CPT book.
Infusion Administration Hierarchy Accuracy
Since CPT requires infusion administration to be billed in a specific hierarchy order, initial, sequential, then concurrent, billing services out of sequence changes reimbursement and can trigger denials. We sequence every infusion encounter to match the hierarchy the documentation actually supports.
J-Code and Dosage Unit Matching
Because every infused or injected drug requires a J-code with units matching the documented dose exactly, a mismatch between what's charted and what's billed is a frequent and preventable denial cause. We verify dosage-to-unit alignment before every drug claim goes out.
Drug Wastage Documentation
Since wastage from single-use vials is separately billable under modifier JW when properly documented, we track wastage as its own line item so this legitimate revenue doesn't go uncaptured.
Prior Authorization for Biologics
Because many hematologic biologics and high-cost therapies carry substantial prior authorization requirements, we verify authorization status well before treatment begins, not after a denial arrives.
Anticoagulation Monitoring Billing
Since anticoagulation management billing depends on whether monitoring happens through point-of-care testing or a standard lab draw, we code monitoring visits to reflect exactly how the testing was performed.
Modifier 25 for Same-Day E/M
When a hematologist evaluates a patient and delivers infusion or injection therapy on the same day, modifier 25 signals the E/M service was separately identifiable. We apply it only when the documentation clearly supports two distinct services.
Hematology-specific, not generalist
Billers who know cath lab bundling rules
A biller who treats every specialty the same way will bill an infusion out of hierarchy order or miss the wastage on a single-use vial, and then never understand why revenue came up short. Since hematology revenue leaks rarely sit in one place, they instead spread across administration hierarchy accuracy, J-code precision, and wastage documentation that most billers never learn to track together. Ultimately, treating hematology like standard internal medicine billing is exactly where the revenue disappears.
Talk to a specialistCaught before submission
Fewer denials, faster reimbursement
Hematology practices without strong front-end controls commonly see first-pass denial rates of 12 to 20%, driven largely by infusion hierarchy sequencing errors, J-code dosage mismatches, and missed prior authorizations on biologics. Because we catch these before the claim goes out rather than after the denial comes back, practices see cleaner claims from the first submission.
See how it works
What we hold ourselves to
Our values, in practice
Intake & Systems Review
We audit current infusion hierarchy coding and J-code documentation practices.
Charge Capture & Coding
Encounters get coded with correct administration sequencing, J-codes, and dosage-matched units.
Claims Scrubbing
Claims run through payer-specific edits before submission.
Submission & Tracking
Clean claims go out daily, and every claim gets tracked to resolution.
Denial Management
Denials get corrected and resubmitted within payer timely-filing windows.
Authorization Monitoring
Biologic and high-cost therapy authorizations get tracked from initiation through approval.
Reporting
Monthly reports show clean claim rate, denial trends, and days in A/R by drug and procedure category.
Questions, answered
Hematology billing, answered
What Hematology practices ask most before switching billing partners.
What makes hematology billing different from other internal medicine subspecialties?
Hematology billing combines infusion and injection administration coding, which follows a strict hierarchy structure, with drug billing under specific J-codes that must match documented dosage exactly. Because this drug-and-administration complexity resembles oncology billing more than standard internal medicine, hematology requires specialized coding fluency most general billers don't have.
Why does infusion administration hierarchy matter for billing?
CPT requires infusion services to be billed in a specific order, starting with the initial service and continuing through sequential and concurrent services, and this order affects reimbursement. Billing out of hierarchy sequence, or missing which service qualifies as initial versus sequential, is a common and preventable source of denials or reduced payment.
Is drug wastage from a single-use vial billable?
Yes, when documentation clearly supports that a portion of a single-use vial went unused and modifier JW is applied correctly. Many practices don't track wastage as a distinct billing line, which means this legitimate revenue often goes uncaptured even though it's a routine part of infusion therapy.
Why do J-code claims get denied for dosage mismatches?
Each J-code represents a specific billing unit of a drug, and the units billed have to match the dose actually administered as documented in the record. When the charted dose and the billed units don't align precisely, the claim denies even when the treatment itself was medically appropriate.
How does anticoagulation monitoring billing work in hematology?
Billing for anticoagulation management depends on whether monitoring happens through point-of-care testing in the office or a standard laboratory draw, since each method uses different coding. Practices need to code based on how the testing was actually performed rather than defaulting to one method across all patients.
What denial rate should a hematology practice expect?
A well-run hematology billing operation should see a denial rate under 7%, with first-pass clean claims above 93%. Practices without strong infusion hierarchy and J-code controls commonly see denial rates well above that, since drug and administration coding errors account for a large share of preventable hematology denials.
Find out how much revenue
your practice is leaving on the table.
Get a free, no-obligation revenue audit. We'll analyze your billing and show you the exact dollars you could be collecting.
No contracts to review. No pressure. Just numbers.